🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Adaptive Intervention Model for Hypertension Self-Management in Rural Areas: A Doctor-Patient Interaction Approach

RecruitingNAAges 18 Years - 80 YearsAllYuju Wu
NCT06869031 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of this project is to develop and validate an adaptive intervention model to improve self-management behavior in rural hypertensive patients. The primary question it seeks to answer is: Can a tailored, interaction-based intervention model, guided by key doctor-patient interaction elements, effectively enhance self-management behavior among rural hypertensive patients and improve long-term blood pressure control? Researchers will evaluate the impact of different intervention strategies on self-management behavior and identify the most effective combination to establish a sustainable intervention model for rural hypertension management.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosed hypertension patients who are permanent residents in rural areas. * No plans for long-term relocation within the next year. * Willing to participate in this study. * No cognitive impairment. * No other diseases that significantly affect self-management behavior, such as malignant tumors. Exclusion Criteria: * Age over 80 years. * Having conditions such as stroke, paralysis, or mental disorders that prevent the completion of self-management behaviors. * Severe hearing impairment or speech disorders that prevent participation in interviews. * Likely to relocate or be away from the local area for an extended period within one year.
💊

What it tests

  • Standard Interactive Intervention for Hypertension Management
  • Intensified Interactive Intervention for Hypertension Management
📍

Where

1 site
West China Fourth Hospital and West China School of Public Health. Sichuan University
Chengdu, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy